Recent news on Formoterol

SYMBICORT trial shows improved quality of life with asthma  -  25 May 2007
News-Medical.net,New data demonstrated that the combination asthma therapy, SYMBICORT (budesonide/formoterol fumarate dihydrate), led to significant improvements in

Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate ...  -  May 21, 2007
PR Newswire (press release),..."Nebulized Formoterol is an Effective Bronchodilator and Improves the Quality of Life for COPD Patients" presented results of the Phase III pivotal clinical

Clinical Trial Data For Perforomistâ„¢ (Formoterol Fumarate)  -  May 21, 2007
Pharmaceutical Online (press release),Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomistâ„¢ (formoterol fumarate) Inhalation

Clinical Trial Data for Perforomist(TM) (Formoterol Fumarate ...  -  May 21, 2007
PR Newswire (press release),New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate

Clinical Trial Data For Perforomist Inhalation Solution Presented ...  -  May 23, 2007
Medical News Today (press release),Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist® (formoterol fumarate) Inhalation

FDA Approves Dey, LP's Perforomist(TM) (Formoterol Fumarate ...  -  May 12, 2007
Medical News Today (press release),Formoterol is a rapid and long-lasting beta(2) agonist that has been previously approved in the US as a dry powder formulation, and the molecule has twenty

FDA Approves Dey, LP's Perforomist(TM) (Formoterol Fumarate ...  -  May 11, 2007
PR Newswire (press release),First nebulized formoterol fumarate offers patients twice-daily dosing for rapid, long-lasting relief of emphysema and chronic bronchitis -- NAPA, Calif.,

Clinical Trial Data for Perforomist(TM) Inhalation Solution to be ...  -  May 16, 2007
PR Newswire (press release),Data from Phase III pivotal trial demonstrate safety and efficacy of first FDA-approved nebulized formoterol fumarate for patients with moderate to severe

Presentation Of Clinical Trial Data For Perforomist Inhalation ...  -  May 17, 2007
Medical News Today (press release),The presentations will detail Phase III clinical data demonstrating the safety and efficacy of Perforomistâ„¢ (formoterol fumarate) Inhalation Solution,

Asthma must be treated as serious  -  May 24, 2007
City Vision,Long-acting ones include salmeterol and formoterol and are used together with an anti-inflammatory drug every day.Work quickly and last for varying periods

Critical Therapeutics Inc. Is Extending It's Gains - Update  -  May 14, 2007
Trading Markets,Critical Therapeutics Inc. on Monday revealed the US Food and Drug Administration approval for Dey, LP's New Drug Application for Perforomist, formoterol

Sufferers Of COPD May Find New FDA-Approved Drug Perforomist A ...  -  May 21, 2007
AHN...may now find new alternative relief in a recently approved Food and Drug Administration (FDA) medication called Perforomist (a nebulized formoterol).

Ranbaxy Q1 2007 Net Profit Rises 79% to Rs.129 Crores  -  Apr 29, 2007
India PRwire (Press Release),The branded division performed well with the launch of Easyhaler Formoterol, adding to the Company's existing products in the respiratory segment.

Mylan to Buy Merck Generics Unit for EUR4.9 Billion (Update2)  -  May 13, 2007
BloombergIt is the first nebulized version of formoterol, previously approved in the US in a powder form. Iceland's Actavis Group hf, Germany's Stada Arzneimittel AG

sanofi-aventis: Full-year Guidance Raised on Good 2007 First ...  -  May 3, 2007
MSN MoneyThe Group's collaboration with Nycomed for the development and the commercialization of the combination product of ciclesonide with formoterol in the US

New Publications Confirm Clinical And Scientific Benefits Of  -  Apr 23, 2007
Pharmaceutical Online (press release),Formoterol is a unique bronchodilator that is rapid in effect, unlike salmeterol, and long lasting. Salmeterol does not have the properties that enable it

Horrillo fails drugs test  -  Apr 19, 2007
News24,The Hague - Spain's Pedro Horrillo has tested positive for Formoterol, a drug used to treat asthma, during the Fleche Wallonne cycling race in Belgium last

Ranbaxy launches asthma drug 'Osovair' in India  -  Mar 30, 2007
domain-B,Mumbai: Ranbaxy Laboratories Ltd has announced the launch of its branded asthma drug, Osovair (formoterol + ciclesonide) inhalation capsules in India.

Ranbaxy launches Asthma inhaler capsule  -  Mar 29, 2007
Andhra Cafe,Ranbaxy Laboratories Ltd. announced the launch of its branded product, Osovair (Formoterol + Ciclesonide) inhalation capsules in India for the treatment of

Ranbaxy launches Osovair for the treatment of Asthma  -  Mar 28, 2007
India PRwire (Press Release),Ranbaxy Laboratories Limited (Ranbaxy) today announced the launch of its branded product, Osovair (Formoterol + Ciclesonide) inhalation capsules in India

Ranbaxy Launches Osovair inhalation capsules in India for the ...  -  Mar 28, 2007
Equity Bulls,Ranbaxy Laboratories Ltd on March 28, 2007 has announced the launch of its branded product, Osovair (Formoterol + Ciclesonide) inhalation capsules in India

Sunny Skyes as injectables business falls to earth  -  Mar 30, 2007
LabTechnologist.com,The big prospect in the current pipeline is the inhalable asthma treatment, Flutiform (fluticasone/formoterol), which is currently in Phase III development.

Ranbaxy Labs book closure from May 25-31  -  Mar 29, 2007
Myiris.com,The company, yesterday, announced the launch of its branded product, Osovair (Formoterol Ciclesonide) inhalation capsules in India .

Ranbaxy launches asthma drug Osovair  -  Mar 28, 2007
Zee News,This product combines long acting beta 2 agonist (Laba) Formoterol and the new inhaled Corticosteroid Ciclesonide. The drug contains 12mcg of Formoterol

Ranbaxy launches Osovair in India  -  Mar 28, 2007
Myiris.com,Osovair, launched for the first time in the world, combines the fastest acting long acting beta 2 Agonist Formoterol and the new inhaled corticosteroid

AstraZeneca's 'big five' drive sales growth in first quarter  -  Apr 24, 2007
Pharma Times (subscription),...rose 15% to $401 million, and the firm's combination product for asthma - Symbicort (budesonide and formoterol) - came in at $354 million, up 19%.

Optimal Treatment of Chronic Obstructive Pulmonary Disease: The ...  -  Apr 16, 2007
Annals of Internal MedicineCalverley PM, Boonsawat W, Cseke Z, Zhong N, Peterson S, Olsson H. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary

Death at county jail under investigation; Autopsy reveals no cause ...  -  Apr 19, 2007
LaCrosse Tribune,...to Brinckman April 12 stating King was allergic to nefazodone, an anti-depressant; promethazine, an antihistamine; formoterol inhalers and wheat gluten.

Skye formulation accepted for GSK drug  -  Apr 16, 2007
In-PharmaTechnologist.com,While not on the scale of the company's hopes for its asthma treatment Flutiform (fluticasone and formoterol), which is seen as a potential billion-dollar

Ranbaxy launches asthma drug in India  -  Mar 28, 2007
CNN-IBN,It contains 12mcg of formoterol making it the first ICS/LABA combination of its type to be approved any where in the world, a company statement said.

Significant asthma control and improved lung function with Symbicort  -  25 Feb 2007
eMaxHealth.com,In addition, these data demonstrated that in comparison to its monocomponents (budesonide and formoterol) and placebo, SYMBICORT and the other treatment

3000 jobs go as AstraZeneca faces up to future challenges - 02/02/2007  -  Feb 2, 2007
Pharma Times (subscription),...breast cancer drug Arimidex (anastrozole) rose 24% to $412 million, and combination product for asthma - Symbicort (budesonide and formoterol) - came in

Frost & Sullivan Lauds Chiesi Farmaceutici SpA for Exceptional ...  -  Feb 15, 2007
PR Newswire (press release),...the portfolio of CFC products including beclomethasone dipropionate, budesonide, ipratropium bromide, formoterol, as well as New Chemical Entities."

Astrazeneca Launches A Smarter Approach To Asthma Management In Europe  -  Feb 14, 2007
Medical News Today (press release),ICS to provide an anti-inflammatory effect in the airways, and formoterol, a unique bronchodilator that is both rapid in effect and long lasting (LABA).

SkyePharma aims for $82m with sale of injectable business  -  Jan 10, 2007
In-PharmaTechnologist.com,SkyePharma is now free to concentrate on other projects, such as their key combination asthma product, Flutiform (fluticasone and formoterol).

Research and Markets: AstraZeneca Now Has Ten Products With Global ...  -  Jan 11, 2007
PharmaLive.com (press release),Symbicort (budesonide+formoterol), an inhaled therapy for asthma and chronic obstructive pulmonary disease (COPD), whose sales in 2005 exceeded the US$1

Beta-Agonists may cause thousands of asthma-related deaths each year  -  Jan 1, 2007
Health SentinelLong-acting beta-agonists, such as salmeterol (Serevent) and formoterol (Foradil) are used to control moderate to severe asthma and prevent nighttime

“Fatal exacerbationâ€? among certain asthma sufferers  -  Jan 11, 2007
Destination Santé,More than 16 months ago Destination Santé revealed that salmeterol and formoterol had been placed on the Index by the US Food and Drug Administration (FDA)

SkyePharma injectables business sale may net $82 million  -  Jan 9, 2007
Pharma Times (subscription),The funds from the latter will be used to finance late-stage studies of combination respiratory drug Flutiform (fluticasone and formoterol),

FDA Approves Foradil(R) Certihaler(TM) (Formoterol Fumarate ...  -  Dec 18, 2006
DG News...the US Food and Drug Administration (FDA) has approved Foradil(R) Certihaler(TM) (formoterol fumarate inhalation powder) for the treatment of asthma.

SkyePharma stock up as FDA approves asthma inhaler  -  Dec 19, 2006
Pharma Times (subscription),The FDA issued only an approvable letter in April 2006 for Foradil Certihaler (formoterol fumarate) due to concerns, highlighted by recalls of the product

FDA Approves Foradil Certihaler  -  Dec 19, 2006
PipelineReview.com (press release),Announces today that the US Food and Drug Administration (FDA) has approved FORADIL(R) CERTIHALER(TM) (formoterol fumarate inhalation powder) for the

SkyePharma Says US FDA Approves Foradil Certihaler - Update  -  Dec 18, 2006
Trading Markets,According to the company, Foradil Certihaler is a multi-dose dry powder inhaler version of the long-acting bronchodilator formoterol.

Foradil Certihaler Approved for Treating Asthma  -  Dec 19, 2006
Facts and Comparisons,The FDA has approved SkyePharma’s Foradil Certihaler (formoterol fumarate inhalation powder) for the treatment of asthma. The FDA issued an approvable

SkyePharma OK'd on asthma inhaler  -  Dec 18, 2006
United Press InternationalThe formoterol-fumarate, inhalation powder-based inhaler was co-developed by SkyePharma and Novartis, and is a trademark of Novartis.

SkyePharma PLC announces FDA approves FORADIL(R) CERTIHALER(TM)  -  Dec 17, 2006
Market Wire (press release)...that the US Food and Drug Administration (FDA) has approved FORADIL® CERTIHALER™ (formoterol fumarate inhalation powder) for the treatment of asthma.

Carriers for DPIs: formulation and regulatory challenges  -  Dec 13, 2006
Pharmaceutical Technology Europe,Additionally, carrier-based higher potency medications exist that require even lower doses (for example; Foradil, formoterol fumarate, 12 μg,

Asthma: 3 steps to better asthma control  -  Dec 12, 2006
MayoClinic.comExamples include salmeterol (Serevent) or formoterol (Foradil). A combination of inhaled corticosteroids and long-acting beta-2 agonists.

SkyePharma PLC announces Positive Flutiform Update  Nov 6, 2006
SkyePharma's product Flutiformâ„¢ consists of a unique fixed-dose combination of the long-acting bronchodilator formoterol with the inhaled steroid fluticasone ... -Market Wire (press release) Mutual Recognition Procedure Completed For Symbicort® Maintenance ...  Oct 10, 2006
...only because Symbicort combines the two components budesonide, an inhaled corticosteroid (ICS) providing anti-inflammatory effect, and formoterol, a unique ... -Medical News Today (press release), DATAMONITOR: Asthma/COPD combo products here to stay  Oct 11, 2006
...such combination inhalers available: GlaxoSmithKline's (GSK) Advair/Seretide (fluticasone/salmeterol) and AstraZeneca's (AZ) Symbicort (budesonide/formoterol). ... -PharmaLive.com (press release), Asthma/COPD Combination Products Here to Stay  Oct 11, 2006
The third combination product on the market is Chiesi's Foster (beclometasone/formoterol), approved in Germany in September 2006. ... -International News Service, AstraZeneca Successfully Completes Mutual Recognition Procedure ...  Oct 9, 2006
SMILE evaluated the benefits of different as needed therapies: budesonide/formoterol, formoterol or terbutaline on top of Symbicort maintenance therapy, in ... -PharmaLive.com (press release), No. 1 treatment for emphysema: Quit smoking  Oct 29, 2006
There are long-acting bronchodilators – such as salmeterol (Serevent), formoterol (Foradil) and tiotropium (Spiriva) – taken once or twice a day to provide ... -Fort Wayne Journal Gazette, Health watchdog to examine risks of asthma drugs  Oct 14, 2006
In Britain, unlike America, most patients are on the safer form of the drug, which is the combination inhaler of Salmeterol or another Laba, Formoterol, with a ... -The Observer, Asthma: 3 steps to better asthma control  -  12 Dec 2006
MayoClinic.comExamples include salmeterol (Serevent) or formoterol (Foradil). A combination of inhaled corticosteroids and long-acting beta-2 agonists.

Inhaled Budesonide/Formoterol Improves Asthma Control and Lung ...  -  Nov 13, 2006
DG NewsThe combination of budesonide and formoterol was approved by the US Food and Drug Administration for maintenance treatment of asthma but is not yet

Asthma :: Approved Asthma Therapy SYMBICORT Improves Lung Function ...  -  Nov 14, 2006
SpiritIndia,Newly presented data indicate that treatment with SYMBICORT® (budesonide/formoterol fumarate dihydrate) inhalation aerosol results in significantly greater

Approved Asthma Therapy SYMBICORT Improves Lung Function Safely ...  -  Nov 13, 2006
Drug Newswire (press release),Long-acting beta2-adrenergic agonists, such as formoterol, may increase the risk of asthma-related death. Therefore, when treating patients with asthma,

Approved Asthma Therapy SYMBICORT Improves Lung Function Safely ...  -  Nov 13, 2006
PR Newswire (press release),Important Safety Information Long-acting beta2-adrenergic agonists, such as formoterol, may increase the risk of asthma-related death.

World anti-doping agency makes changes in banned substances for 2007  -  Nov 15, 2006
Indian Muslims,Most sport supporters would need a medical dictionary to figure out the bulk of the changes such as salbutamol, salmeterol, terbutaline and formoterol being

New GINA Guidelines Provide Supportive Statements For Symbicort ...  -  Nov 20, 2006
Medical News Today (press release),Both components of budesonide-formoterol given as-needed contribute to enhanced protection from severe exacerbations in patients receiving combination

Novel Beta Agonist Indacaterol Safe and Effective in Short-Term ...  -  Nov 20, 2006
DG NewsCurrent combination treatments, such as fluticasone/salmeterol (Advair Diskus) and budesonide/formoterol (Symbicort) are given twice daily, and according to

AstraZeneca banking on asthma inhaler  -  Nov 19, 2006
The News Journal,It combines budesonide, an inhaled corticosteroid, and formoterol, a beta agonist. Together, they improve lung function in patients with moderate-to-severe

Market Report -- In Play (AZN)  -  Nov 13, 2006
MSN Money...significantly greater improvements in lung function, and a lower risk of asthma worsening episodes, compared to budesonide and/or formoterol used alone.

ACAAI: Servent Plus Inhaled Steroid Said to Reduce Asthma ...  -  Nov 13, 2006
MedPage Today,Serevent (salmeterol) and Foradil (formoterol) due to findings of increased risk of serious adverse events and a small increase in respiratory deaths,



Increased Uptake of Expensive Maintenance Therapies will Help ...  11 Apr 2006
Pfizer's Spiriva (tiotropium), GlaxoSmithKline's Advair/Seretide (fluticasone/salmeterol), and AstraZeneca's Symbicort (budesonide/formoterol), will be driven ... - PR Newswire

AstraZeneca Welcomes Preliminary Results From TORCH  Mar 28, 2006
Reduction of exacerbations is an area where the budesonide / formoterol ICS/LABA therapy (marketed by AstraZeneca as Symbicort(R)) has strong clinical data. ... - APA OTS (Pressemitteilung)

AstraZeneca Welcomes Preliminary Results from TORCH  Mar 29, 2006
Reduction of exacerbations is an area where the budesonide / formoterol ICS/LABA therapy (marketed by AstraZeneca as Symbicort®) has strong clinical data. ... - PharmaLive.com

Cystic fibrosis: hope remains for a 'miracle cure'  Mar 30, 2006
...used treatments are a combination inhaled corticosteroids and beta2-agonists, such as AstraZeneca's Symbicort (budesonide/formoterol) and GlaxoSmithKline's ... - Pharmaceutical Business Review

American Journal of Respiratory and Critical Care Medicine Vol 173 ...  Mar 28, 2006
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129–136. ... - AJRCCM (subscription)

SkyePharma defeats shareholder revolt  Mar 10, 2006
They have been particularly upset by the lack of a licensing partner for Flutiform (formoterol plus fluticasone), a combination drug for asthma which has been ... - Pharma Times (subscription)

Orion Oyj: Orion group 2005 financial statements  Feb 9, 2006
Ranbaxy in England. Budesonide and formoterol are being launched to the market as new choices in the Easyhaler franchise. Orion Pharma ... - Kauppalehti,

Meda AB (publ): Year-End 2005 Report  Feb 22, 2006
96% to more than SEK 240 million for all of 2005 - after launch of Novolizer budesonide 200 mcg in many European countries and of Novolizer formoterol on the ... - Genetic Engineering News,

Altana's asthma drug Alvesco granted additional approval for ...  Feb 16, 2006
Alvesco is also in phase III trials as a nasal spray, and in phase II trials as a combination treatment with long-acting beta-agonist formoterol. ... - Forbes

Toprol XL uncertainty weighs heavy on AstraZeneca  Feb 3, 2006
...lipid-lowerer Crestor (rosuvastatin), Arimidex (anastrozole) for breast cancer and combination asthma treatment Symbicort (budesonide and formoterol). ... - Pharma Times (subscription),

Orion Oyj: Orion group 2005 financial statements  09 Feb 2006
Ranbaxy in England. Budesonide and formoterol are being launched to the market as new choices in the Easyhaler franchise. Orion Pharma ... - Kauppalehti

DATAMONITOR: Get SMART: Symbicort gives patients the power to ...  Jan 11, 2006
LONDON, January 11 2006- AstraZeneca is developing a new indication for its current leading asthma medication Symbicort (budesonide/formoterol), known as ... - PharmaLive.com

AstraZeneca's Symbicort gives asthma patients the power to get ...  Jan 13, 2006
AstraZeneca is focusing on Symbicort's (budesonide/formoterol) adaptability for adjustable dosing though SMART, which was formerly known as 'Single inhaler ... - Pharmaceutical Business Review

Breaking News ** Profits surge at AstraZeneca in Q4  Feb 2, 2006
...lipid-lowerer Crestor (rosuvastatin), Arimidex (anastrozole) for breast cancer and combination asthma treatment Symbicort (budesonide and formoterol). ... - Pharma Times (subscription)

New Symbicort dose a boon for AstraZeneca?  Jan 11, 2006
...allergy drugs advisory committee recommended that a warning of the concerns about long-acting beta-2 agonists also be applied to Novartis`s Foradil (formoterol ... - Monsters and Critics.com

SkyePharma will not merge with Innovata  Jan 12, 2006
...that will improve its cash position as it continues a costly effort to bring a combination inhaled product for asthma - Flutiform (formoterol plus fluticasone ... - Pharma Times (subscription)

Verus Pharmaceuticals Appoints Tutuncu as Vice President, Medical ...  Jan 25, 2006
As Medical Director for pulmonary products, he developed and implemented clinical plans for late-stage products including budesonide, formoterol and Flutiform ... - PharmaLive.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional